Delpor Inc - Company & Market Research Reports

Delpor company enables the sustained or pattern specific release of proteins, peptides, and small molecules through a small non-mechanical subcutaneous implant device. They use 3 different technologies: Prozor, Nanopor, and Delos Pump. Delpor was founded in 2009, its headquarters is situated in San Francisco, California. Delpors DLP-114 is a 3-6 month formulation of Risperidone. This product is using Delpors Prozor technology It is expected to maintain therapeutic levels of Risperidone and its active metabolite in human plasma.

From
From
From
Type 2 Diabetes - Pipeline Review, H1 2018 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2018

  • Drug Pipelines
  • 1109 Pages
From
Type 2 Diabetes - Pipeline Review, H2 2017 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H2 2017

  • Drug Pipelines
  • 1126 Pages
From
Schizophrenia - Pipeline Review, H2 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H2 2018

  • Drug Pipelines
  • 321 Pages
From
D Antagonist -Pipeline Insight, 2018 - Product Thumbnail Image

D Antagonist -Pipeline Insight, 2018

  • Drug Pipelines
  • 90 Pages
From
Schizophrenia - Pipeline Review, H1 2018 - Product Thumbnail Image

Schizophrenia - Pipeline Review, H1 2018

  • Drug Pipelines
  • 334 Pages
From
From
From
Depression - Pipeline Review, H2 2018 - Product Thumbnail Image

Depression - Pipeline Review, H2 2018

  • Drug Pipelines
  • 504 Pages
From
Depression - Pipeline Review, H1 2018 - Product Thumbnail Image

Depression - Pipeline Review, H1 2018

  • Drug Pipelines
  • 490 Pages
From
From
From
From
Loading Indicator
adroll